People struggling with many addictions, ranging from opioids to gambling, are reporting similar experiences in clinics, on ...

Evidence is mounting that the wildly popular weight-loss medicines known as GLP-1s may also hold potential for treating addiction, and the field may be on the verge of obtaining desperately needed ...

GLP-1 drugs, originally developed for diabetes and obesity, may also curb addictive behaviors by acting on reward circuits in the brain. Early trials show reductions in alcohol intake, opioid seeking, ...

The popular class of weight loss drugs known as GLP-1s have shown to be effective in curbing cravings beyond food. A few early studies have suggested that GLP-1 medications can do a lot to alleviate ...

Remarkable scientific progress over the past five decades has helped us develop knowledge of how drugs of abuse induce pleasure, reinforce use, and lead to the compulsive self-administration we call ...

Named by the Evening Standard as one of the top 100 people shaping London in 2025, Professor David Nutt has authored over 500 research papers and more than 30 books. One of the world’s foremost ...

Ana Clara Bobadilla receives funding from the National Institute on Drug Abuse and the Brain & Behavior Research Foundation. Everyday human behavior is guided and shaped by the search for rewards.